BIOMAT Database Logo BIOMAT Database Logo

[The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease]. 1969

G Eggerth, and J Kühböck, and D Pokorny

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

G Eggerth, and J Kühböck, and D Pokorny
[Delayed reaction of Hodgkin's disease lymphocytes to phytohemagglutinin].
September 1969, Deutsche medizinische Wochenschrift (1946),
G Eggerth, and J Kühböck, and D Pokorny
[Studies on the influence of plasma in Hodgkin's disease on phytohemagglutinin transformation of normal lymphocytes].
January 1968, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
G Eggerth, and J Kühböck, and D Pokorny
[Effect of phytohemagglutinin on mouse peripheral lymphocytes].
January 1967, Tumori,
G Eggerth, and J Kühböck, and D Pokorny
[Effect of phytohemagglutinin on the cytotoxic activity of lymphocytes].
January 1980, Doklady Akademii nauk SSSR,
G Eggerth, and J Kühböck, and D Pokorny
[The blood lymphocytes under the light- and electron microscope after stimulation with phytohemagglutinin. II. Phytohemagglutinin transformation of lymphocytes by Hodgkin's disease and chronic lymphatic leukemia].
January 1969, Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimentelle Chirurgie,
G Eggerth, and J Kühböck, and D Pokorny
Effect of phytohemagglutinin on lymphocytes from different leukemias.
January 1965, Texas reports on biology and medicine,
G Eggerth, and J Kühböck, and D Pokorny
Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
December 1975, Clinical oncology,
G Eggerth, and J Kühböck, and D Pokorny
Lymphocyte response to phytohemagglutinin in Hodgkin's disease.
June 1970, The American journal of medicine,
G Eggerth, and J Kühböck, and D Pokorny
Effect of sera from patients with Hodgkin's disease on normal lymphocyte response to phytohemagglutinin.
June 1972, Cancer,
G Eggerth, and J Kühböck, and D Pokorny
Effect of phytohemagglutinin on human blood lymphocytes irradiated in vitor.
January 1969, Strahlentherapie,
Copied contents to your clipboard!